Polymeric nanoparticle-mediated in situ co-delivery of RNAi and chemotherapy drugs for cancer immunotherapy

Time: 4:00 pm
day: Conference Day Two


  • Introducing a polymeric nanoparticle system that is highly effective in tumor targeting through effective tumor EC-mediated active targeting while minimizing LSEC-mediated liver uptake
  • Outlining the effectiveness of controlling tumor growth using this dual treatment strategy that can simultaneously co-deliver chemotherapy drugs with novel immunotherapies
  • Spotlighting the translational effect of targeting Xkr8 in combination with chemotherapy for the treatment of various types of cancers in clinic